Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Kezar Life Sciences (KZR) Other Non-Current Assets (2021 - 2025)

Kezar Life Sciences' Other Non-Current Assets history spans 4 years, with the latest figure at $674000.0 for Q2 2025.

  • For Q2 2025, Other Non-Current Assets changed N/A year-over-year to $674000.0; the TTM value through Jun 2025 reached $674000.0, changed N/A, while the annual FY2024 figure was $2.4 million, N/A changed from the prior year.
  • Other Non-Current Assets for Q2 2025 was $674000.0 at Kezar Life Sciences, roughly flat from $674000.0 in the prior quarter.
  • Across five years, Other Non-Current Assets topped out at $2.4 million in Q4 2024 and bottomed at $282000.0 in Q1 2021.
  • The 4-year median for Other Non-Current Assets is $282000.0 (2021), against an average of $582818.2.
  • The largest YoY upside for Other Non-Current Assets was 139.01% in 2022 against a maximum downside of 0.0% in 2022.
  • A 4-year view of Other Non-Current Assets shows it stood at $282000.0 in 2021, then surged by 139.01% to $674000.0 in 2022, then skyrocketed by 258.31% to $2.4 million in 2024, then plummeted by 72.09% to $674000.0 in 2025.
  • Per Business Quant, the three most recent readings for KZR's Other Non-Current Assets are $674000.0 (Q2 2025), $674000.0 (Q1 2025), and $2.4 million (Q4 2024).